earnings

Horizon Therapeutics Reports Q4 Results, Beats Revenue Target
Motley Fool
Wed, 02/26/20 - 11:21 pm
Horizon Therapeutics
earnings
Amarin: Is It Time to Test the Waters?
Motley Fool
Wed, 02/26/20 - 10:41 am
Amarin
earnings
Clovis Oncology's Sales Growth Slows in Q4
Motley Fool
Tue, 02/25/20 - 10:05 am
Clovis Oncology
earnings
Ortho, spine players Smith & Nephew, NuVasive and Globus post Q4 results
Medtech Dive
Fri, 02/21/20 - 11:50 pm
devices
earnings
Smith & Nephew
NuVasive
Globus Medical
Emergent BioSolutions Reports Mixed Results for Q4
Motley Fool
Fri, 02/21/20 - 11:41 pm
Emergent BioSolutions
earnings
Repligen Signals Gene Therapy Strength With 2019 Earnings Report
Motley Fool
Fri, 02/21/20 - 11:39 pm
Repligen
earnings
gene therapy
How Masimo Blew Past Wall Street Estimates in Q4
Motley Fool
Thu, 02/20/20 - 10:27 am
Masimo
earnings
devices
Why Elanco Animal Health's Q4 Results Didn't Have Much Bite
Motley Fool
Wed, 02/19/20 - 11:29 pm
Elanco
animal health
earnings
What's Behind Bausch Health's Disappointing Q4 Earnings Results
Motley Fool
Wed, 02/19/20 - 11:28 pm
earnings
devices
Motley Fool
bluebird bio Beats Its Q4 Revenue Target but Misses on EPS
Motley Fool
Wed, 02/19/20 - 09:51 am
Bluebird Bio
earnings
Medtronic misses revenue estimates as TAVR position falters
Medtech Dive
Tue, 02/18/20 - 08:15 pm
Medtronic
devices
earnings
AstraZeneca cans cancer pipeline efforts
Fierce Biotech
Fri, 02/14/20 - 10:49 am
AstraZeneca
earnings
R&D
cancer
oncology
How Zoetis Beat Expectations Yet Again with Its Q4 Results
Motley Fool
Thu, 02/13/20 - 11:27 pm
Zoetis
earnings
animal health
Incyte Earnings, Revenue Beat in Q4
Yahoo/Investing.com
Thu, 02/13/20 - 11:00 am
Incyte
earnings
Teva Pharmaceutical Reports a Step Back in 2019
Motley Fool
Thu, 02/13/20 - 12:10 am
Teva Pharmaceutical
earnings
How Allergan Beat Estimates in What's Likely Its Last Quarterly Update
Motley Fool
Mon, 02/10/20 - 11:39 pm
Allergan
earnings
Biotech Q4 Earnings Synopsis: Major Restructuring and Overall Growth Are Themes
BioSpace
Mon, 02/10/20 - 10:19 am
earnings
Bristol-Myers Squibb
AbbVie
Novo Nordisk
Merck
GSK
Seattle Genetics
Gilead Sciences: Still on the Path to Recovery
Motley Fool
Sun, 02/9/20 - 04:17 pm
Gilead Sciences
earnings
Myriad Genetics CEO Mark Capone Resigns
Motley Fool
Fri, 02/7/20 - 11:49 pm
Myriad Genetics
Mark Capone
Pharma CEOs
earnings
AbbVie Tops Q4 Profit Forecast, Sees Solid 2020 as New Drugs Boost Sales
TheStreet.com
Fri, 02/7/20 - 10:54 am
AbbVie
earnings

Pages